ATX-101: Clinical Trials

8 trials of ATX-101, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 38Completed 8

Follow ATX-101: new trials by email Literature Review of ATX-101 trials Research Report on ATX-101

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age
ATX-101, Placebo - Moderate to Severe Convexity of Submental Fat, Safety
Phase 3CompletedKythera Biopharmaceuticals552014-04-012020-02-17
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
ATX-101, Placebo - Submental Fat, Healthy
Phase 3CompletedKythera Biopharmaceuticals2242013-12-012020-02-17
Patient Experience Study of Deoxycholic Acid Injection
Deoxycholic Acid Injection, Placebo, Cold Compress - Moderate or Severe Submental Fullness
Phase 3CompletedKythera Biopharmaceuticals842013-12-012015-07-28
Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area
Deoxycholic acid injection, Placebo - Moderate or Severe Submental Fullness
Phase 3CompletedKythera Biopharmaceuticals5162012-03-012015-06-15
Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area
Deoxycholic acid injection, Placebo - Moderate or Severe Submental Fullness
Phase 3CompletedKythera Biopharmaceuticals5062012-02-012015-06-15
Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area
Deoxycholic acid injection - Moderate or Severe Submental Fullness
Phase 3CompletedKythera Biopharmaceuticals1652011-08-012016-01-14
Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat
Deoxycholic acid injection, Placebo - Moderate or Severe Submental Fullness
Phase 3CompletedKythera Biopharmaceuticals3602011-01-012015-06-12
Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat
Deoxycholic acid injection, Placebo - Moderate or Severe Submental Fullness
Phase 3CompletedKythera Biopharmaceuticals3632010-12-012015-07-14

Conditions studied

Lymphoma, Follicular (6)

Sponsors

Kythera Biopharmaceuticals (8)

Countries

United States (6)  ·  Canada (3)  ·  Belgium (2)  ·  France (2)  ·  Germany (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Italy (1)

Top investigators

Frederick Beddingfield, MD, PhD (4)  ·  Frederick Beddingfield, III, MD, PhD (3)  ·  Frederick Beddingfield, III, M.D., PhD (1)

Results publications

PMID 24984785, PMID 27787269, PMID 31524342, PMID 33617632